Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company BioArctic AB
DescriptionHeparin-activated recombinant human fibroblast growth factor 1 (FGF-1) inserted on a biodegradable device made from alpha-calcium sulphate hemihydrate
Molecular Target Fibroblast growth factor 1 (FGF1)
Mechanism of ActionFibroblast growth factor (FGF) receptor (FGFR) agonist
Therapeutic ModalityMedical Devices: Drug/device combination
Latest Stage of DevelopmentPhase I/II
Standard IndicationSpinal cord injury (SCI)
Indication DetailsTreat traumatic spinal cord injury (SCI)
Regulatory Designation EU - Orphan Drug (Treat traumatic spinal cord injury (SCI))

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today